- Home
- BHC vs GOF Comparison
BHC vs GOF Comparison
Compare BHC & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHC | GOF |
|---|---|---|
| Founded | N/A | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BHC | GOF |
|---|---|---|
| Price | $5.77 | $12.84 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 789.2K |
| Earning Date | 02-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 15.42% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.97 | N/A |
| Revenue | ★ $10,029,000,000.00 | N/A |
| Revenue This Year | $6.81 | N/A |
| Revenue Next Year | $4.11 | N/A |
| P/E Ratio | $6.00 | ★ N/A |
| Revenue Growth | ★ 5.86 | N/A |
| 52 Week Low | $4.25 | $10.96 |
| 52 Week High | $8.69 | $16.76 |
Technical Indicators
Market Signals| Indicator | BHC | GOF |
|---|---|---|
| Relative Strength Index (RSI) | 26.32 | 53.76 |
| Support Level | $7.23 | $12.74 |
| Resistance Level | $7.73 | $12.93 |
| Average True Range (ATR) | 0.30 | 0.15 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 3.48 | 52.43 |
Price Performance
Historical ComparisonAbout BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.